Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

计划入组 17 人 · 首次发布于 2010 年 9 月 23 日

Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project

计划入组 183 人 · 首次发布于 2016 年 10 月 28 日

Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone

计划入组 30 人 · 首次发布于 2017 年 8 月 23 日

Tag-7 gene modified autologous tumor cell vaccine

Tumor Cell Vaccines(NCI)

TTRNA-DC vaccine/TTRNA-xALT immunotherapy (University of Florida)

Giant Compressed Gases Inc

United States

Stiftung Swiss Tumor Institute

Switzerland

National Center for Tumor Diseases

Germany

Pimicotinib Shows Promise in Phase III Trial for Tenosynovial Giant Cell Tumor

Pimicotinib Meets Primary Endpoint in Phase III Trial for Tenosynovial Giant Cell Tumor

Vimseltinib Shows Durable Two-Year Efficacy in Tenosynovial Giant Cell Tumor Phase 3 Trial